TrialPloS one2018

Cost-effectiveness of everolimus-eluting versus bare-metal stents in ST-segment elevation myocardial infarction: An analysis from the EXAMINATION randomized controlled trial.

Nadine Schur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.